Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta.
about
Advances in the treatment of cervical rheumatoid: Less surgery and less morbidityA Novel Allosteric Inhibitor of Macrophage Migration Inhibitory Factor (MIF)In vitro model for the analysis of synovial fibroblast-mediated degradation of intact cartilage.Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling.Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritisLack of association of matrix metalloproteinase-3 gene polymorphism with susceptibility to rheumatoid arthritis: a meta-analysis.Matrix metalloproteases and tissue inhibitors of metalloproteinases in medial plica and pannus-like tissue contribute to knee osteoarthritis progression.Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritisIdentification of arthritis-related gene clusters by microarray analysis of two independent mouse models for rheumatoid arthritis.Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.Boiogito, a Kampo medicine, improves hydrarthrosis in a rat model of knee osteoarthritisDrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner.Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases.Proteinases in the joint: clinical relevance of proteinases in joint destructionDevelopments in the synovial biology field 2006.Cells of the synovium in rheumatoid arthritis. Chondrocytes.A 129-kb deletion on chromosome 12 confers substantial protection against rheumatoid arthritis, implicating the gene SLC2A3.Effects of low-dose tacrolimus therapy in combination with methotrexate in patients with methotrexate-refractory rheumatoid arthritis.The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets.Inhibition of epidermal growth factor receptor tyrosine kinase ameliorates collagen-induced arthritis.TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.
P2860
Q26825270-B0D45F65-3865-45D0-8284-EFD74786AB0BQ27670700-619A3DE3-E848-4854-A4C8-F4061F2D4666Q33410403-E8045F6B-8EFF-4669-A6AA-DCDDFFAA33ACQ33893095-2BEA9E98-BA8D-4AD7-847E-9A84C3B0E727Q34027510-A035E6A1-5FAF-4DEB-AF55-C23039541FE3Q34587358-ECB4C50B-3297-42AB-8AB1-EF584930C143Q35041457-8D6B5550-DCC0-434F-8BB1-DE42C1225803Q35223319-51715B25-CD1B-4E6E-A609-2A6F73CAB4C9Q35605572-F8B5AABA-D861-4DBF-BA1F-BECE3C1CCEE7Q35605620-2AC9A666-A7E2-4D95-8396-8B4D2627C0E7Q35878160-1E659026-FC2E-4A67-A6E2-6D0B63D0A248Q36010298-E81350A2-3C5D-4A70-B55F-578AD3FBD73DQ36278589-5B462E70-2020-4AB7-8BC4-A38280DD6090Q36357390-89D42FE2-F735-45E8-8585-3404E78DBA1BQ36401848-AC0738C4-48DF-435C-B291-E4A3DDCB84F1Q36794899-9FBFF54B-B75D-4B89-B1C8-AB74FCEB23F4Q37000837-914CF1BD-6F9D-4092-9A05-1187121107C4Q37715658-8F9A4900-B1AB-4EB4-A1FA-AE2A5AE4B404Q41534957-11222FF7-BAA3-47CF-8340-1124462861B6Q41821312-769766AF-3C51-48B2-9740-2B56E7B241F4Q42568723-73B14C33-2BBE-4299-9B76-8D82D23F4DFBQ47142963-16266F66-6806-4B43-9FAF-93465EA4E513Q55023431-350102A2-3427-4EC4-80A1-A7C405408B7D
P2860
Pannus invasion and cartilage degradation in rheumatoid arthritis: involvement of MMP-3 and interleukin-1beta.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Pannus invasion and cartilage ...... f MMP-3 and interleukin-1beta.
@en
Pannus invasion and cartilage ...... f MMP-3 and interleukin-1beta.
@nl
type
label
Pannus invasion and cartilage ...... f MMP-3 and interleukin-1beta.
@en
Pannus invasion and cartilage ...... f MMP-3 and interleukin-1beta.
@nl
prefLabel
Pannus invasion and cartilage ...... f MMP-3 and interleukin-1beta.
@en
Pannus invasion and cartilage ...... f MMP-3 and interleukin-1beta.
@nl
P2093
P1476
Pannus invasion and cartilage ...... of MMP-3 and interleukin-1beta
@en
P2093
J A Mandelin
M P Liljeström
Y T Konttinen
P304
P577
2005-09-01T00:00:00Z